304 related articles for article (PubMed ID: 28498390)
21. LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b.
Fan Y; Sheng W; Meng Y; Cao Y; Li R
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):393-407. PubMed ID: 31913710
[TBL] [Abstract][Full Text] [Related]
22. miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells.
Song J; Li Y
Cancer Sci; 2017 Jan; 108(1):23-31. PubMed ID: 27743413
[TBL] [Abstract][Full Text] [Related]
23. MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh's esophageal squamous cell carcinoma.
Dai F; Liu T; Zheng S; Liu Q; Yang C; Zhou J; Chen Y; Sheyhidin I; Lu X
Tumour Biol; 2016 Nov; 37(11):14595-14604. PubMed ID: 27619676
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-200b inhibits epithelial-mesenchymal transition and migration of cervical cancer cells by directly targeting RhoE.
Cheng YX; Chen GT; Chen C; Zhang QF; Pan F; Hu M; Li BS
Mol Med Rep; 2016 Apr; 13(4):3139-46. PubMed ID: 26935796
[TBL] [Abstract][Full Text] [Related]
25. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
[TBL] [Abstract][Full Text] [Related]
27. MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression.
Yang K; Li YW; Gao ZY; Xiao W; Li TQ; Song W; Zheng J; Chen H; Chen GH; Zou HY
Int J Biol Macromol; 2019 Mar; 125():557-565. PubMed ID: 30543885
[TBL] [Abstract][Full Text] [Related]
28. Aberrantly enhanced melanoma-associated antigen (MAGE)-A3 expression facilitates cervical cancer cell proliferation and metastasis via actuating Wnt signaling pathway.
Gao X; Chen G; Cai H; Wang X; Song K; Liu L; Qiu T; He Y
Biomed Pharmacother; 2020 Feb; 122():109710. PubMed ID: 31918280
[TBL] [Abstract][Full Text] [Related]
29. MiR-4524b-5p/WTX/β-catenin axis functions as a regulator of metastasis in cervical cancer.
Li T; Zhou W; Li Y; Gan Y; Peng Y; Xiao Q; Ouyang C; Wu A; Zhang S; Liu J; Fan L; Han D; Wei Y; Shu G; Yin G
PLoS One; 2019; 14(4):e0214822. PubMed ID: 30939162
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-218 inhibits EMT, migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical cancer.
Jiang Z; Song Q; Zeng R; Li J; Li J; Lin X; Chen X; Zhang J; Zheng Y
Oncotarget; 2016 Jul; 7(29):45622-45636. PubMed ID: 27285984
[TBL] [Abstract][Full Text] [Related]
31. Expression of miR-106b-25 induced by salvianolic acid B inhibits epithelial-to-mesenchymal transition in HK-2 cells.
Tang Q; Zhong H; Xie F; Xie J; Chen H; Yao G
Eur J Pharmacol; 2014 Oct; 741():97-103. PubMed ID: 25094038
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
Luo M; Shen D; Zhou X; Chen X; Wang W
Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
[TBL] [Abstract][Full Text] [Related]
33. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
34. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
[TBL] [Abstract][Full Text] [Related]
35. Regulatory effects of CCDC3 on proliferation, migration, invasion and EMT of human cervical cancer cells.
Zhang XF; An MZ; Ma YP; Lu YM
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3217-3224. PubMed ID: 31081073
[TBL] [Abstract][Full Text] [Related]
36. Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer.
Huang W; Zhu S; Liu Q; Li C; Li L
Int J Clin Exp Pathol; 2014; 7(12):8506-19. PubMed ID: 25674215
[TBL] [Abstract][Full Text] [Related]
37. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of MiR-205 under hypoxia promotes epithelial-mesenchymal transition by targeting ASPP2.
Wang X; Yu M; Zhao K; He M; Ge W; Sun Y; Wang Y; Sun H; Hu Y
Cell Death Dis; 2016 Dec; 7(12):e2517. PubMed ID: 27929537
[TBL] [Abstract][Full Text] [Related]
39. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X
Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition.
Wu X; Xi X; Yan Q; Zhang Z; Cai B; Lu W; Wan X
Med Oncol; 2013 Dec; 30(4):751. PubMed ID: 24158756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
